期刊文献+

3D打印减压鞋垫在糖尿病足防治中的临床应用 被引量:15

Application of 3D-printed decompression insole for the prevention of diabetic foot
下载PDF
导出
摘要 目的探讨3D打印减压鞋垫在糖尿病足防治中的临床效果。方法选取2016年1月至2017年3月收治的高危糖尿病足患者62例,所有患者Wagner分级均0级。利用随机数字表法将患者进行左右足自身对照研究,治疗组穿着3D打印糖尿病足减压鞋垫,对照组穿着普通鞋垫。采用比利时Footscan足底压力步态分析仪对两组患者进行穿鞋垫前后动态足底压力的监测,以及B超检测足底血流变化。对两组患者进行1年的随访,观察治疗前后两组患者足底峰值压强、动脉收缩期峰值血流速度(peak orterial systolic flow velocity,PASV)、足溃疡发生率等。结果治疗前患者双足足底各区域峰值压强比较,差异无统计学意义(P>0. 05);治疗1年后,治疗组患者第2、5跖骨底部、足跟区域及第1趾底主要负重区域峰值压强均低于本组治疗前,治疗前后差异均有统计学意义(P<0. 05)。治疗后对照组、治疗组足溃疡发生率分别为16. 1%和5. 0%,两组间差异有统计学意义(P<0. 05)。治疗后治疗组第1、5跖骨底、足跟内侧PASV均高于本组治疗前,差异有统计学意义(P<0. 05)。结论 3D打印减压鞋垫可均匀分布足底压力,纠正糖尿病高足压患者异常受力情况,降低足溃疡发生率,减少截肢率,保障糖尿病患者的生活质量,为预防糖尿病患者糖尿病足病的发生提供经济有效的方式。 Objective To evaluate the application of decompression shoe pad for diabetic foot by3D-printing.Methods Sixty-two patients with high risk of diabetic foot were recruited in our hospital from January 2016 to March 2017.All patients were classified as grade 0 according to Wagner classification.The patients were randomly assigned in two groups:31 patients with the left feet and another 31 patients with the right feet wearing 3D-printed decompression insole(study group),and the other feet of 62 patients were cushioned with common insole(control group).The dynamic foot pressure before and after cushioning the insole was monitored by Belgian Footscan foot pressure gait analyzer,and the changes in the blood flow of the foot were detected by ultrasonography.The patients were followed up for1years,and the peak pressure of the foot,the peak arterial systolic flow velocity(PASV)and the incidence of foot ulcer were observed before and after the treatment in two groups.Results There was no significant differences in the peak pressure between the two feet of all the patients before treatment(P>0.05).After1years of treatment,the peak pressure of the mainly weighed region including the second,fifth metatarsal,the heel area and the first toe in the study group was lower than that before the treatment.The differences between study and control groups were statistically significant(P<0.05).After treatment,the incidence of foot ulcers in the control group and the treatment group were16.1%and5%,respectively(P<0.05).The PASV of the first,the fifth metatarsal and the medial heel after treatment in study group were all higher than those before the treatment(P<0.05).Conclusion The 3D-printed decompression insole can evenly distribute sole pressure,correct abnormal stress and reduce the incidence of foot ulcers in patients with high risk of diabetic foot,which provides an economic and effective way to prevent the occurrence of diabetic foot.
作者 陈薇薇 张国锋 陈育宏 谭军 CHEN Wei-wei;ZHANG Guo-feng;CHEN Yu-hong;TAN Jun(Dept. of Orthopedics, East Hospital, Tongji University, Shanghai 200120, China;Dept. of Hand and Foot Surgery, Affiliated Hospital of Medical School of Ningbo University, Ningbo 315000, Zhejiang Province, China)
出处 《同济大学学报(医学版)》 CAS 2018年第6期76-81,共6页 Journal of Tongji University(Medical Science)
基金 上海市浦东新区领先人才计划(PWRd-2011-02 PWR12012-03)
关键词 糖尿病足 3D打印 减压鞋垫 峰值压强 动脉收缩期峰值血流速度 diabetic foot 3D-printing decompression insole peak pressure peak arterial systolic flow velocity
  • 相关文献

参考文献6

二级参考文献51

  • 1罗晋,叶春生,黄树槐.FDM系统的重要工艺参数及其控制技术研究[J].锻压装备与制造技术,2005,40(6):77-80. 被引量:43
  • 2熊小青,冯晓宁.三维打印快速原型机技术分析[J].铸造技术,2006,27(12):1387-1389. 被引量:15
  • 3Anoop Kumar Sood,R.K. Ohdar,S.S. Mahapatra.Parametric appraisal of mechanical property of fused deposition modelling processed parts[J].Materials and Design.2009(1)
  • 4Jack G. Zhou,Daniel Herscovici,Calvin C. Chen.Parametric process optimization to improve the accuracy of rapid prototyped stereolithography parts[J].International Journal of Machine Tools and Manufacture.1999(3)
  • 5Ward A,Alvarez P, Vo L,et al. Direct medical costs of compli- cations of diabetes in the United States: estimates for event- year and annual state costs (USD2012). J Med Econ, 2014,17: 176-183.
  • 6Schaper NC, Netten JJV, Apelqvist J, et al. Prevention and management of foot problems in diabetes: a summary guidance for daily practice 2015, based on the MGDF guidance docu- ments. Diabe/metabo Resea Revie, 2'016, 32(Suppl $1) .. 7-15.
  • 7Boulton AJ, Armstrong DG, Albert SF, et al. Comprehensive foot examination and risk assessment. Endocr Pratt, 2008, 14.- 576-583.
  • 8Melmed S,Polonsky KS, Larsen PR,et al. Wflhams textbook ofen- docrino]ogy: Expert consult. Elsevier Health Sciences, 2011, 1506-1507.
  • 9Lavery LA,La Fontaine J,Kim PJ. Preventing the first or re- current ulcers. Med Clin North Am,2013,97:807-820.
  • 10Sveen KA, Karime B, Jorum E, et al. Small- and large-fiber neuropathy after 40 years of type 1 diabetes: associations with glycemic control and advanced protein glycation:the Oslo Stud-y. Diabetes Care,2013,36:3712-3717.

共引文献166

同被引文献147

引证文献15

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部